 |
PDBsum entry 4cd3
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hydrolase
|
 |
|
Title:
|
 |
Rnntpdase2 x4 variant in complex with psb-071
|
|
Structure:
|
 |
Ectonucleoside triphosphate diphosphohydrolase 2. Chain: a. Fragment: ectodomain, residues 28-462. Synonym: ntpdase 2, cd39 antigen-like 1, ecto-atp diphosphohydrolase 2, ecto-atpdase 2, ecto-atpase 2, ntpdase2. Engineered: yes. Mutation: yes
|
|
Source:
|
 |
Rattus norvegicus. Norway rat. Organism_taxid: 10116. Expressed in: escherichia coli. Expression_system_taxid: 562
|
|
Resolution:
|
 |
|
2.19Å
|
R-factor:
|
0.182
|
R-free:
|
0.236
|
|
|
Authors:
|
 |
M.Zebisch,P.Schaefer,N.Straeter
|
|
Key ref:
|
 |
M.Zebisch
et al.
(2014).
Crystal structure of NTPDase2 in complex with the sulfoanthraquinone inhibitor PSB-071.
J Struct Biol,
185,
336-341.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
29-Oct-13
|
Release date:
|
12-Feb-14
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
O35795
(ENTP2_RAT) -
Ectonucleoside triphosphate diphosphohydrolase 2 from Rattus norvegicus
|
|
|
|
Seq: Struc:
|
 |
 |
 |
495 a.a.
421 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
*
PDB and UniProt seqs differ
at 4 residue positions (black
crosses)
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Struct Biol
185:336-341
(2014)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of NTPDase2 in complex with the sulfoanthraquinone inhibitor PSB-071.
|
|
M.Zebisch,
Y.Baqi,
P.Schäfer,
C.E.Müller,
N.Sträter.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
In many vertebrate tissues CD39-like ecto-nucleoside triphosphate
diphosphohydrolases (NTPDases) act in concert with ecto-5'-nucleotidase (e5NT,
CD73) to convert extracellular ATP to adenosine. Extracellular ATP is a
cytotoxic, pro-inflammatory signalling molecule whereas its product adenosine
constitutes a universal and potent immune suppressor. Interference with these
ectonucleotidases by use of small molecule inhibitors or inhibitory antibodies
appears to be an effective strategy to enhance anti-tumour immunity and suppress
neoangiogenesis. Here we present the first crystal structures of an NTPDase
catalytic ectodomain in complex with the Reactive Blue 2 (RB2)-derived inhibitor
PSB-071. In both of the two crystal forms presented the inhibitor binds as a
sandwich of two molecules at the nucleoside binding site. One of the molecules
is well defined in its orientation. Specific hydrogen bonds are formed between
the sulfonyl group and the nucleoside binding loop. The methylphenyl side chain
functionality that improved NTPDase2-specificity is sandwiched between R245 and
R394, the latter of which is exclusively found in NTPDase2. The second molecule
exhibits great in-plane rotational freedom and could not be modelled in a
specific orientation. In addition to this structural insight into NTPDase
inhibition, the observation of the putative membrane interaction loop (MIL) in
two different conformations related by a 10° rotation identifies the MIL as a
dynamic section of NTPDases that is potentially involved in regulation of
catalysis.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |